Taiwan FDA registration 5bc1512ce4adcf6b5025fc3a677bd4d6

"Leica" Novocastra Liquid Mouse Monoclonal Antibody Multi-Cytokeratin (Non-Sterile)

TW: "徠卡" 諾法卡特老鼠抗人類角蛋白抗體 (未滅菌)

Taiwan·Risk Class 1·MD·LEICA BIOSYSTEMS NEWCASTLE LTD.·Registered Mar 24, 2016 – Mar 24, 2026Expired

Registration details

Analysis ID: 5bc1512ce4adcf6b5025fc3a677bd4d6
License Form: Ministry of Health Medical Device Import No. 016313
Customs Code: DHA09401631304

Company information

Manufacturer: LEICA BIOSYSTEMS NEWCASTLE LTD.
Manufacturer Country: United Kingdom
Authorized Representative: BOND BIOTECH, INC.

Product details

Intended Use: Limited to the first level identification range of immunopathological histochemical reagents and kits (B.1860) of the Measures for the Administration of Medical Devices.
Product Type (Level 1): B Hematology and pathology devices
Product Type (Level 2): B1860 Immunopathological histochemical reagents and kits
Import Information: Imported from abroad

Dates and status

Registration Date: Mar 24, 2016
Expiry Date: Mar 24, 2026

About this record

Access comprehensive regulatory information for "Leica" Novocastra Liquid Mouse Monoclonal Antibody Multi-Cytokeratin (Non-Sterile) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number 5bc1512ce4adcf6b5025fc3a677bd4d6 and manufactured by LEICA BIOSYSTEMS NEWCASTLE LTD.. The authorized representative in Taiwan is BOND BIOTECH, INC..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.